Schedule 13G ownership disclosure
ASPIRE BIOPHARMA HLDGS INC
Common Stock · CUSIP: 738920107
Event date: 2025-03-03
- Filing-level shares
- 4,609,375.00
- Percent of class
- 9.462%
- Lance Friedman
Shares: 4,609,375.00 · Class: 9.462%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-000116
- Form type
- SCHEDULE 13G/A
- Filer
- Aspire Biopharma Holdings, Inc.
- CIK
- CIK 1847345
- Filed
- Mar 20, 2025
- Reporting period
- Mar 03, 2025
- Description
- Schedule 13G beneficial ownership